Kasiak Research

Mumbai, India Founded: 2009 • Age: 17 yrs
Develops innovative stem cell-based therapies for treating diabetic foot ulcers.

About Kasiak Research

Kasiak Research was a Healthcare company based in Mumbai (India) founded in 2009. It develops innovative stem cell-based therapies for treating diabetic foot ulcers. It operates on a B2B model. Its Indian entity Kasiak Research Private Limited Cn reported revenue of β‚Ή27.6 Lakh. The company is recorded as dissolved. Its focus areas include Biotechnology, Medical Research and Therapeutics Development.

Company details

Kasiak Research develops innovative stem cell-based therapies for treating diabetic foot ulcers, focusing on providing healthcare solutions, advancing biotech innovations, conducting medical research, and therapeutics development. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets.

Key Metrics
  • Annual Revenue
    ₹27.6 Lakh

    FY 2017 · -50% YoY

  • Net Loss
    -₹39.8 Lakh

    FY 2017 · -246% margin

  • EBITDA
    -₹17.9 Lakh

    FY 2017 · -110% margin

Board of directors of Kasiak Research Private Limited Cn (Kasiak Research)

Kasiak Research Private Limited Cn is the primary company behind Kasiak Research. The board of Kasiak Research Private Limited Cn currently have 3 directors; the longest-serving is Bharat Vinod Daftary, appointed in 2007. 8 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Bharat Vinod Daftary
DIN 00011518
Director16 May 200719 yrs 6 moKasiak Research Private Limited Cn
Gautam Vinod Daftary
DIN 00009326
Director16 May 200719 yrs 6 moKasiak Research Private Limited Cn
Girish Bakre
DIN 00010760
Director01 Aug 201313 yrs 3 moKasiak Research Private Limited Cn

Financials of Kasiak Research

Figures of Kasiak Research Private Limited Cn, the primary company behind Kasiak Research, for FY 2017. Revenue was ₹27.6 Lakh (-50% year on year). Net loss was -₹39.8 Lakh (-246% margin). EBITDA was -₹17.9 Lakh (-110% margin). Revenue has grown at a compounded annual rate of -42% over three years.

  • ₹27.6 LakhRevenue · FY 2017 · -50% YoY
  • -₹39.8 LakhNet loss · -246% margin
  • -₹17.9 LakhEBITDA · -110% margin
  • ₹2.2 LakhPaid-up capital
  • -42%Revenue CAGR, 3 years

Balance sheet, profit and loss, cash flow and ratios of Kasiak Research Private Limited Cn are on its company page.

Premium access

Detailed financial statements for Kasiak Research

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Top companies in Clinical Trials & Research Tech

2 companies that operate in the same segment as Kasiak Research (Clinical Trials & Research Tech) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Drug development services encompassing clinical trials, bioanalytical support, and real-world evidence in healthcare.
2004Ahmedabad, Gujarat, IndiaUSD 74.68 M1,618
Generic injectables for oncology and anesthesiology are manufactured.
1989Hyderabad, Telangana, IndiaUSD 4.22 M228
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Kasiak Research

Kasiak Research was founded in 2009.

Kasiak Research is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.

The primary company behind Kasiak Research, Kasiak Research Private Limited Cn, reported revenue of β‚Ή27.6 Lakh for FY 2017, down 50% year on year.

Kasiak Research develops innovative stem cell-based therapies for treating diabetic foot ulcers, focusing on providing healthcare solutions, advancing biotech innovations, conducting medical research, and therapeutics development. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets.

Kasiak Research operates through Kasiak Research Private Limited Cn.

The legal entities of Kasiak Research currently have 3 directors, including Girish Bakre, Bharat Vinod Daftary, Gautam Vinod Daftary.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available